Plenary Speakers (as of July 25, 2016)
Presentation title: 'The Global Virome'
Dr. Dennis Carroll currently serves as the Director of the U.S. Agency for International Development's (USAID) Global Health Security and Development Unit. In this position Dr. Carroll is responsible for providing strategic and operational leadership for the Agency's programs addressing new and emerging disease threats.

Dr. Carroll was initially detailed to USAID from the U.S. Centers for Disease Control and Prevention as a senior public health advisor in 1991. In 1995 he was named the Agency's Senior Infectious Diseases advisor, responsible for overseeing the Agency's programs in malaria, tuberculosis, antimicrobial resistance, disease surveillance, as well as neglected and emerging infectious diseases. In this capacity Dr. Carroll was directly involved in the development and introduction of a range of new technologies for disease prevention and control, including: community-based delivery of treatment of onchocerciasis, rapid diagnostics for malaria, new treatment therapies for drug resistant malaria, intermittent therapy for pregnant women and "long-lasting" insecticide treated bednets for prevention of malaria. He was responsible for the initial design and development of the President's Malaria Initiative. Dr. Carroll officially left CDC and joined USAID in 2005 when he assumed responsibility for leading the USAID response to the spread of avian influenza.

Dr. Carroll has a doctorate in biomedical research with a special focus in tropical infectious diseases from the University of Massachusetts at Amherst. He was a Research Scientist at Cold Spring Harbor Laboratory where he studied the molecular mechanics of viral infection. Dr. Carroll has received awards from both CDC and USAID, including the 2006 USAID Science and Technology Award for his work on malaria and avian influenza, the 2008 Administrator's Management Innovation Award for his management of the Agency's Avian and Pandemic Influenza program, and in 2015 USAID's Distinguished Service Award.

Dr. Peter Daszak is President of EcoHealth Alliance, a US-based organization that conducts research and outreach programs on global health, conservation and international development. His research focuses on the origins of emerging diseases, and on strategies to reduce the risk of new EIDs and benefit conservation. Dr Daszak is Editor-in-Chief of EcoHealth, a member of the editorial board of One Health, and is a member of the IOM's Forum on Microbial Threats, the NRC Advisory Committee to the US Global Change Research Program, and the Supervisory Board of the One Health Platform. He has authored over 300 scientific papers.


Rudovick KAZWALA, Tanzania
Presentation title: 'Zoonotic Diseases at the Human - Domestic Animal - Wildlife Interface in Southern and Eastern Africa'

Professor Kazwala is a graduate of BVSc  at Sokoine University of Agriculture, MVM (University College Dublin, Ireland) and  PhD (University of Edinburgh, UK). He is the Professor of Ecosystems and Public Health  in the Department of Veterinary Medicine and Public Health. Prof. Kazwala is involved in a number of research projects particularly in area of bacterial and viral zoonoses. Prof. Kazwala has supervised more than 40 postgraduate students in over 15 research projects, and has published more than 100 articles in international journals.

He is the Chairman of Veterinary Council of Tanzania, and is a member of the Tanzania Food and Drug Authority, Food Technical Committee. In addition, Prof. Kazwala supported the development of the Livestock Sector Development Strategy for Tanzania.
He is a member of the International Health Regulations, Roster of Experts in Veterinary Issues, Zoonoses, and coordinates the Bovine Tuberculosis Network for Africa.

Since 2010, Prof. Kazwala has led the USAID Emerging Pandemic Threats Program PREDICT Project in Tanzania, supporting the development of a wildlife disease surveillance and early warning system for high-risk viral pathogens, and overseeing the development of a new molecular laboratory for emerging infectious diseases and pathogen discovery at Sokoine University of Agriculture.


Christine Kreuder JOHNSON, United States
Presentation title: 'Evidence for a Risk-based Strategy to Detect Viral Spillover and Spread'

Christine Kreuder Johnson is Professor of Epidemiology and Associate Director of the One Health Institute in the School of Veterinary Medicine at UC Davis where she directs the EpiCenter for Disease Dynamics. Her research activities focus on zoonotic disease spillover dynamics, epidemiologic drivers of zoonotic disease transmission and spread, ecosystem level processes that impact wildlife population health, and mechanisms underlying species declines. She provides epidemiologic support to national and state agencies during unusual outbreak events and has developed and implemented risk-based approaches for surveillance and standardized risk assessment to enable systematic data analysis across a range of field studies from the local to global scale. At UC Davis, her accomplishments include the design of core didactic instruction in one health, ecosystem health, and epidemiology for graduate and professional degree programs and major mentorship to over 40 graduate students and post-doctoral scholars.

Since 2014, Professor Johnson has directed global surveillance activities for USAID's Emerging Pandemic Threats PREDICT program. Along with a team of Consortium scientists, she guides field activities towards situations with highest risk of disease spillover, develops surveillance measures and indicators, and coordinates surveillance and disease outbreak investigations. Prior to arriving at UC Davis to earn a Ph.D. in Epidemiology, she graduated with distinction from Duke University, obtained a veterinary degree (V.M.D.) from the University of Pennsylvania, and worked as an equine and wildlife veterinarian.


Julio PINTO, Italy
Presentation title: 'Global Early Warning Signs for Health Threats at the Human Animal Ecosystem Interface'
Julio Pinto (DVM, PhD) joined the Animal Health Service in FAO in May 2006. Having graduated in Veterinary Science in the University of Chile in 1994, he completed his PhD studies in Veterinary Epidemiology and Economics at The University of Reading, United Kingdom, in 2000 completing his thesis on "Hazard analysis of classical swine fever (CSF) reintroduction in Chile".

Dr Pinto joined the World Organisation for Animal Health (OIE) in Paris where he worked in the animal health information department and international trade issues related to animal health between February 2003 and May 2006. In June 2006 he joined the FAO's Animal Health and Production Division in Headquarters in Rome. Since then, Dr Pinto is leading the FAO's Global Disease Intelligence and Early Warning program, and responsible for disease intelligence, information systems and projects related to animal disease surveillance and risk assessment and strengthening epidemiology capacities in veterinary services. Dr. Pinto is leading the development of FAO's global animal health information system for animal diseases (EMPRES-i) and mobile technologies tools for disease reporting and surveillance (EMA-i) implemented in Uganda and Zanzibar (Tanzania). He is the technical focal point from FAO to the Joint FAO/OIE/WHO Global Early Warning System for Animal Diseases and Zoonosis (GLEWS+).

He is providing regular technical assistance to countries or regions in the assessment, design and implementation of disease surveillance programs, field disease outbreak investigation, good emergency management practices, animal health information systems, prevention and control of animal diseases, supporting animal health policies, and technical backstopping to animal health systems worldwide.


Mercedes TATAY, Switzerland
Presentation title: 'Emergency Responses Including the European Migrant Crisis'

Dr Mercedes Tatay is the International Medical Secretary of Médecins Sans Frontières (MSF) since February 2016.

A specialist in infectious diseases and tropical medicine, Dr Tatay joined MSF in 1998 and has worked in a number of conflict and epidemic settings, including in Tanzania, Sierra Leone, Burundi, Zambia, CAR, Liberia, Afghanistan, Niger, Ivory Coast, Uganda, Sudan and the Democratic Republic of Congo. This allowed her to develop expertise in operational management and medical programme planning in complex humanitarian emergency contexts. Dr Tatay became Head of Emergency Programs with MSF France, and from 2003 to 2007 she oversaw humanitarian interventions in Iraq, Jordan, Sudan, Chad, CAR, Pakistan, Sri Lanka, Indonesia, Lebanon, Haiti, Nigeria, Ivory Coast, Liberia, Angola, DRC, Philippines and Niger among others (conflicts, epidemics and natural disasters).

Later on, Dr Tatay practised as an infectious diseases physician in two university teaching hospitals infectious diseases and tropical medicine departments in France until 2015.

In 2015, she worked as a consultant for WHO in infection prevention and control as well as in field coordination during the Ebola outbreak response in Sierra Leone. She also took coordination responsibilities as part of the UN Country team leadership.

Her teaching experience includes clinical seminars and trainings on infectious diseases, applied epidemiology, operational management emergency response and humanitarian medicine.


Gabriel M LEUNG
Presentation title: 'Satisficing Control Options for Influenza'

Prof. Gabriel Leung is Dean of Medicine and Chair Professor of Public Health Medicine at the University of Hong Kong. Previously he was Hong Kong's Under Secretary for Food and Health, then Director of the Chief Executive's Office in government.

Prof. Leung is one of Asia's leading epidemiologists, having authored more than 400 scholarly papers and edited numerous journals. He directs the University of Hong Kong's WHO Collaborating Centre for Infectious Disease Epidemiology and Control. His research defined the epidemiology of two novel viral epidemics, namely SARS-CoV in 2003 and influenza A(H7N9) in 2013. While in government, he led Hong Kong's policy response against the 2009 influenza A(H1N1) pandemic.

Most recently, Prof. Leung served on the Commission on a Global Health Risk Framework for the Future led by the US National Academy of Medicine; the International Expert Group Convening on Pandemic Emergency Preparedness for G7 Summit; the Harvard-LSHTM Independent Panel on the Global Response to Ebola and was an expert reviewer for the United Nations Secretary-General High-level Panel on the Global Response to Health Crises.
Dominique L. Monnet
Presentation title: 'Trends in Antimicrobial Resistance in Europe'

Dr. Dominique L. Monnet is Head of the Antimicrobial Resistance & Healthcare-Associated Infections (ARHAI) Programme at the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden.

Dr. Monnet joined ECDC in October 2007 to lead ECDC's Disease Programme on Antimicrobial Resistance and Healthcare-Associated Infections.  He is also representing ECDC in the EU-US Transatlantic Task Force on Antimicrobial Resistance (TATFAR).

Before joining ECDC, he worked in French hospitals, at the US Centers for Disease Control and Prevention (1993-1995) and at the Danish Statens Serum Institut (1997-2007) where he was coordinating surveillance of antimicrobial resistance and antimicrobial consumption in humans in Denmark.

Dr. Monnet's research interests include surveillance of antimicrobial resistance and antimicrobial consumption, the relationship between consumption of antimicrobials and resistance, and the factors that affect antimicrobial usage, both in hospitals and in primary care.

Ab Osterhaus
Presentation title: 'AIDS, Avian flu, SARS, MERS, Ebola, Zika …What Next?'

As professor of Virology in Rotterdam and Utrecht, The Netherlands, and in Hannover, Germany, Ab Osterhaus has had a long track record as scientific researcher and PI of numerous major scientific projects.

At Erasmus MC he ran the >40 persons virology diagnostic lab and the >100 persons virology research lab. His research programme followed a novel integrated “viroscience” concept, bringing together world leading scientists in molecular virology, immunology, epidemiology, pathogenesis, and intervention studies on human and animal virus infections.

After having handed over the chairmanship of the Erasmus MC Viroscience lab in 2014, he is currently establishing new One Health Institutes in Hannover and Utrecht.
Major performances include the discovery of more than 50 new viruses of humans and animals (e.g. human metapneumovirus, human coronaviruses, influenza viruses), elucidation of the pathogenesis of major human and animal virus infections, and development of novel intervention strategies. This has enabled health authorities like WHO, to effectively combat disease outbreaks like SARS and avian influenza. The spin-off, Viroclinics Biosciences BV, is another societally relevant success, allowing effective testing and refining of diagnostic tools and other intervention strategies.

Awards, prizes, guest lecture invitations, (co-)organisership of international meetings and editorships of scientific journals further highlight his international recognition. He has acted as PhD mentor for more than 75 students, holds several key patents and is the author of more than 1100 papers in peer-reviewed journals, together cited more than 50,000 times, and his current H index is 97. He is Editor-in-Chief of two major Elsevier Journals. Most of all, Ab Osterhaus firmly believes scientists have a role to play in translating their knowledge for the benefit and protection of society.